These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20712585)

  • 1. Metformin and energy metabolism in breast cancer: from insulin physiology to tumour-initiating stem cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Martin-Castillo B; Menendez JA
    Curr Mol Med; 2010 Oct; 10(7):674-91. PubMed ID: 20712585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin is synthetically lethal with glucose withdrawal in cancer cells.
    Menendez JA; Oliveras-Ferraros C; Cufí S; Corominas-Faja B; Joven J; Martin-Castillo B; Vazquez-Martin A
    Cell Cycle; 2012 Aug; 11(15):2782-92. PubMed ID: 22809961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: taking away the candy for cancer?
    Jalving M; Gietema JA; Lefrandt JD; de Jong S; Reyners AK; Gans RO; de Vries EG
    Eur J Cancer; 2010 Sep; 46(13):2369-80. PubMed ID: 20656475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin.
    Wysocki PJ; Wierusz-Wysocka B
    Expert Rev Mol Diagn; 2010 May; 10(4):509-19. PubMed ID: 20465505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial targets of metformin-Are they physiologically relevant?
    Pecinová A; Brázdová A; Drahota Z; Houštěk J; Mráček T
    Biofactors; 2019 Sep; 45(5):703-711. PubMed ID: 31343786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer research. Cancer prevention with a diabetes pill?
    Taubes G
    Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
    [No Abstract]   [Full Text] [Related]  

  • 9. A review for clinicians: Prostate cancer and the antineoplastic properties of metformin.
    Hankinson SJ; Fam M; Patel NN
    Urol Oncol; 2017 Jan; 35(1):21-29. PubMed ID: 27836248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin: "Old warrior for a new battle".
    Jain A
    Indian J Cancer; 2010; 47(4):471-2. PubMed ID: 21131766
    [No Abstract]   [Full Text] [Related]  

  • 11. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
    Vona-Davis L; Rose DP
    Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial metabolism and type-2 diabetes: a specific target of metformin.
    Leverve XM; Guigas B; Detaille D; Batandier C; Koceir EA; Chauvin C; Fontaine E; Wiernsperger NF
    Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S88-94. PubMed ID: 14502105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
    Markowicz-Piasecka M; Sikora J; Szydłowska A; Skupień A; Mikiciuk-Olasik E; Huttunen KM
    Pharm Res; 2017 Dec; 34(12):2614-2627. PubMed ID: 28589443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and neoplasia: implications and indications.
    Aljada A; Mousa SA
    Pharmacol Ther; 2012 Jan; 133(1):108-15. PubMed ID: 21924289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study.
    Dowling RJ; Niraula S; Chang MC; Done SJ; Ennis M; McCready DR; Leong WL; Escallon JM; Reedijk M; Goodwin PJ; Stambolic V
    Breast Cancer Res; 2015 Mar; 17(1):32. PubMed ID: 25849721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
    An H; He L
    J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications.
    Bashraheel SS; Kheraldine H; Khalaf S; Moustafa AA
    Biomed Pharmacother; 2023 Jun; 162():114676. PubMed ID: 37037091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective Effects of Metformin.
    Driver C; Bamitale KDS; Kazi A; Olla M; Nyane NA; Owira PMO
    J Cardiovasc Pharmacol; 2018 Aug; 72(2):121-127. PubMed ID: 29738369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.